Novavax (NASDAQ:NVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Novavax missed estimated earnings by 521.11%, reporting an EPS of $-11.18 versus an estimate of $-1.8.
Revenue was up $54.46 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.4 which was followed by a 11.27% drop in the share price the next day.
Here's a look at Novavax's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -3.91 | -3.63 | -3.60 | -1.49 |
| EPS Actual | -4.31 | -4.75 | -3.05 | -2.70 |
| Revenue Estimate | 334.62M | 387.87M | 233.90M | 304.88M |
| Revenue Actual | 178.84M | 298.02M | 447.23M | 276.66M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
